Publication | Closed Access

Verapamil and angiotensin-converting enzyme inhibitors in patients with coronary artery disease and reduced left ventricular ejection fraction

Angiotensin-converting Enzyme InhibitorsHypertensionHeart FailureCardiovascular DiseaseMedicineAtherosclerosisVentricular Ejection FractionCardiovascular PharmacologyPharmacotherapyPharmacologyCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionMyocardial Infarction